Singapore – TriNetX global health research network announced that it has signed on to CHRISTUS Health (a US-based Catholic health system). CHRISTUS Health has decided to standardize on the TriNetX network as their conduit to sponsored clinical trials.
"CHRISTUS Health's partnership with TriNetX will enhance our clinical research activities and accelerate our ability to identify patients and their timely inclusion in selected clinical trials," said Sohail Rao, MD, MA, DPhil, System Vice President for Research and Academics and Chief Academic Officer at CHRISTUS Health. "It will allow us to undertake protocol design, selection of appropriate sites, collaborative research and grant funding opportunities across a range of therapeutic areas and development stages."
TriNetX is a network comprised of healthcare organizations representing over 84 million patients globally, biopharmaceutical companies, and contract research organizations (CROs). Network members utilize TriNetX's health research platform to analyze patient populations with search criteria across multiple longitudinal data points. TriNetX's advanced analytics modules provide intelligence on the most impactful criteria as well as identifying the rate at which new patients present. Each de-identified data point in the TriNetX network can be traced to healthcare organizations who then are able to identify individual patients. Researchers can discover patients for industry-sponsored and investigator-initiated studies, as well as for collaboration with peer research institutions.
